Perdays Australia issued infringement notice for the alleged unlawful advertising of a therapeutic good

The Therapeutic Goods Administration (TGA) has issued an infringement notice, to the value of $19,800, to PERDAY'S HEALTH FUNCTIONAL FOOD (AU) PTY LTD (Perdays Australia) for the alleged unlawful advertising of a listed medicine, in contravention of the Therapeutic Goods Act 1989 (the Act).

Perdays Australia paid the infringement notice in October 2025.

The therapeutic goods regulatory framework allows sponsors to supply low risk listed medicines to consumers, without the requirement for pre-market assessment of efficacy, quality, and safety by the TGA.

These listed medicines may only use pre-approved low level therapeutic claims that will not lead to unsafe or inappropriate use by consumers. Advertising listed medicines with therapeutic claims that have not been pre-approved undermines the regulatory framework, potentially exposing consumers to avoidable risk.

The TGA will continue to take action where non-compliance with the Act is identified in accordance with our regulatory compliance framework. This may include cancellation from the ARTG, infringement notices, or civil or criminal proceedings.

If you suspect non-compliance in relation to therapeutic goods or their advertising, you can report it to the TGA at any time.

Contact for members of the media:

• Email:  news@health.gov.au
• Phone: 02 6289 7400